Estrogens in the Treatment of Prostatic Cancer

[1]  V. J. O'conor,et al.  Long-term survivor of prostatic carcinoma with lung metastases. , 1981, The Journal of urology.

[2]  L. Denis,et al.  Bilateral orchiectomy in patients with progressive advanced prostatic cancer. , 1980, Acta urologica Belgica.

[3]  J. Mulder,et al.  EORTC protocols in prostatic cancer. An interim report. , 1980, Scandinavian journal of urology and nephrology. Supplementum.

[4]  P. Walsh,et al.  Long-term survival after hormonal therapy for stage D prostatic cancer. , 1979, The Journal of urology.

[5]  J. Altwein.  Hormontherapie des Prostatakarzinoms , 1979 .

[6]  J. Young,et al.  Adenocarcinoma of prostate: Role of 17β-estradiol and 5α-dihydroterosterone binding proteins , 1979 .

[7]  E. Schmiedt,et al.  [The prognostic significance of cytologic differentiation grades of estrogen-treated prostata carcinoma. Progress control of 496 prostate carcinoma patients treated with estrogen for five years (author's transl)]. , 1978, Der Urologe. Ausg. A.

[8]  J. Williams.  Book Review: Scientific Foundations of Urology , 1978 .

[9]  R. Stutzman,et al.  Plasma testosterone in patients receiving diethylstilbestrol. , 1978, Urology.

[10]  U. Seal,et al.  A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen‐treated responsive and refractory human prostatic carcinoma , 1977, Cancer.

[11]  E. Cooper,et al.  Sex hormone binding globulin in carcinoma of the prostate. , 1977, British journal of urology.

[12]  D. Paulson,et al.  The clinical spectrum of prostate cancer. , 1977, The Journal of urology.

[13]  D. Byar,et al.  Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer , 1976, Cancer.

[14]  D. Byar,et al.  Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer , 1976, Cancer.

[15]  E. F. Hawkins,et al.  Steroid receptors in the human prostate. 2. Some properties of the estrophilic molecule of benign prostatic hypertrophy. , 1976, Biochemical and biophysical research communications.

[16]  M. Eisen,et al.  Inhibition of platelet aggregation caused by estrogen treatment in patients with carcinoma of the prostate. , 1975, The Journal of urology.

[17]  P. Walsh.  Physiologic basis for hormonal theapy in carcinoma of the prostate. , 1975, The Urologic clinics of North America.

[18]  J. Jenkins,et al.  Effect of oestradiol-17beta and progesterone on the metabolism of testosterone by human prostatic tissue. , 1974, The Journal of endocrinology.

[19]  B. Troen,et al.  Studies of the human testis. IV. Testicular 20 alpha-hydroxysteroid dehydrogenase and steroid 17 alpha-hydroxylase. , 1974, Biochimica et biophysica acta.

[20]  D. Horrobin,et al.  PROLACTIN AND THE IMMUNE RESPONSE , 1974 .

[21]  E. N. Cole,et al.  Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens. , 1974, European journal of cancer.

[22]  David C. Anderson,et al.  SEX‐HORMONE‐BINDING GLOBULIN , 1974, Clinical endocrinology.

[23]  J. D. Fergusson,et al.  Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. , 1973, British journal of urology.

[24]  D. Byar.  The veterans administration cooperative urological research group's studies of cancer of the prostate , 1973, Cancer.

[25]  H. Burger,et al.  EFFECTS OF SYNTHETIC ORAL OESTROGENS IN NORMAL MEN AND PATIENTS WITH PROSTATIC CARCINOMA: LACK OF GONADOTROPHIN SUPPRESSION BY CHLOROTRIANISENE , 1973, Clinical endocrinology.

[26]  F. Orestano,et al.  [Intra- and extracellular electrolyte concentration of estrogen therapy on patients with carcinoma of the prostate (author's transl)]. , 1973, Der Urologe. Ausg. A.

[27]  N. Bruchovsky,et al.  Studies on the relationship between androgen receptors and the transport of androgens in rat prostate. , 1973, The Journal of biological chemistry.

[28]  R. Terry,et al.  The effects of treatment on the local lesion of carcinoma of the prostate. , 1973, The Journal of urology.

[29]  D. Byar,et al.  Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma. , 1973, The Journal of urology.

[30]  E. Gursel,et al.  A possible role of Sertoli cells in prostatic cancer refractory to estrogen: a preliminary report. , 1972, The Journal of urology.

[31]  B. Troen,et al.  Studies of the human testis. 3. Effect of estrogen on testosterone formation in human testis in vitro. , 1972, The Journal of clinical endocrinology and metabolism.

[32]  P. Gr,et al.  The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate. , 1972 .

[33]  B. Thomas,et al.  Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic Carcinoma , 1971, British medical journal.

[34]  Y. Oki,et al.  Properties of testosterone 5 -reductase of purified nuclear fraction from ventral prostate of rats. , 1971, Endocrinologia japonica.

[35]  E. Belt,et al.  [Estrogen treatment of prostatic cancer after total prostatectomy: rates of survival and cardiovascular complications in the Mellinger-Belt series]. , 1971, Der Urologe.

[36]  P. Esposti.  Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. A five-year follow-up study of 469 hormone-treated patients. , 1971, Scandinavian journal of urology and nephrology.

[37]  Harrison Jh,et al.  Estrogen and survival data in carcinoma of the prostate. , 1970 .

[38]  K. Griffiths,et al.  The effect of some stilboestrol compounds on DNA polymerase from human prostatic tissue. , 1970, Steroids.

[39]  E. Sotaniemi,et al.  Effect of oestrogen on liver function of prostatic cancer patients , 1969, British medical journal.

[40]  R. Barnes,et al.  Early prostatic cancer: long-term results with conservative treatment. , 1969, The Journal of urology.

[41]  A. Goldman.  Further Studies of Steroidal Inhibitors of Δ5,3β-Hydroxysteroid Dehydrogenase and Δ5-Δ4,3-Ketosteroid Isomerase in Pseudomonas testosteroni and in Bovine Adrenals , 1968 .

[42]  H. H. Young,et al.  Plasma testosterone levels in patients with prostatic carcinoma before and after treatment. , 1968, The Journal of urology.

[43]  R. A. Huseby,et al.  THE EFFECT OF DIETHYLSTILBOESTROL ON TESTICULAR 17ALPHA-HYDROXYLASE AND 17-DESMOLASE ACTIVITIES IN BALB/C MICE. , 1964, Acta endocrinologica.

[44]  J. Meites,et al.  Effect of Estrogen Administration in vivo on Prolactin Release by Rat Pituitary in vitro. ∗, † , 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[45]  H. Brendler,et al.  A cooperative group study of prostatic cancer: stilbestrol versus placebo in advanced progressive disease. , 1962, Cancer chemotherapy reports.

[46]  J. Emmett,et al.  Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies. , 1960, Transactions of the American Association of Genito-Urinary Surgeons.

[47]  L. M. Franksm.  SOME COMMENTS ON THE LONG‐TERM RESULTS OF ENDOCRINE TREATMENT OF PROSTATIC CANCER1 , 1958 .

[48]  R. Baker.  STUDIES ON CANCER PREVENTION IN UROLOGY. I. PROSTATE , 1953, Annals of surgery.

[49]  W. Baum,et al.  Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases. , 1950, Journal of the American Medical Association.

[50]  E. Belt.  Radical Perineal Prostatectomy in Early Carcinoma of the Prostate1 , 1942 .